Colistin utilization at a tertiary hospital in South Africa: an opportunity for antimicrobial stewardship practices
Journal of Medical Microbiology · 2024
DOI: 10.1099/jmm.0.001840 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Microbiology, 2024. Verfasst von Gaalebale Prudence Matshediso und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Public Health, Faculty of Health Sciences, University of Fort Hare, East London, South Africa. Hauptthemen laut MEDLINE: Colistin, Tertiary Care Centers, Antimicrobial Stewardship, Anti-Bacterial Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 29 Literaturangaben.
Abstract (Originalsprache)
Introduction
Colistin (polymyxin E) has emerged as a last-resort treatment option for multidrug-resistant infections. Hypothesis/Gap Statement. Studies on the use, safety and efficacy of colistin in South Africa are limited.
Aim
This study aims to describe the use of colistin and its clinical outcomes at a tertiary public hospital in South Africa. Methodology. We conducted a retrospective review of adult and paediatric patients who received parenteral colistin between 2015 and 2019.
Results
A total of 69 patients (26 adults, 13 children and 30 neonates) were reviewed. Acinetobacter baumannii was the most common causative pathogen isolated (70.1 %). Colistin was predominately used to treat septicaemia (75.4 %). It was primarily administered as definitive therapy (71.0 %) and as monotherapy (56.5 %). It was used in 11.5 % of adults with infections susceptible to other antibiotics. Loading doses of intravenous colistin were administered in only 15 (57.7 %) adult patients. Neurotoxicity and nephrotoxicity occurred in 5.8 % and 43.5 % of patients, respectively. Clinical cure was achieved in 37 (53.6 %) patients. On multivariate logistic regression analysis, adults [adjusted odds ratio (aOR), 25.54; 95 % CI, 2.73–238.65; P < 0.01] and children (aOR, 8.56; 95 % CI, 1.06–69.10; P < 0.05) had higher odds of death than neonates.
Conclusion
The study identified significant stewardship opportunities to improve colistin prescription and administration. Achieving optimal patient outcomes necessitates a multidisciplinary approach and vigilant monitoring of colistin use.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Public Health, Faculty of Health Sciences, University of Fort Hare, East London, South Africa.
- Department of Infection and Tropical Medicine, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.
- Department of Microbiology, University Hospitals of Derby and Burton NHS Foundation Trust, Derby, UK.
- Department of Family Medicine, Cecilia Makiwane Hospital, Faculty of Medicine & Health Sciences, Walter Sisulu University, East London 5200, South Africa.
Zitieren
APA
Matshediso, G. P., Durojaiye, O. C., & Adeniyi, O. V. (2024). Colistin utilization at a tertiary hospital in South Africa: an opportunity for antimicrobial stewardship practices. Journal of Medical Microbiology. https://doi.org/10.1099/jmm.0.001840
Vancouver
Matshediso GP, Durojaiye OC, Adeniyi OV. Colistin utilization at a tertiary hospital in South Africa: an opportunity for antimicrobial stewardship practices. Journal of Medical Microbiology. 2024. doi:10.1099/jmm.0.001840
BibTeX
@article{Matshediso2024,
author = {Matshediso, Gaalebale Prudence and Durojaiye, Oyewole Christopher and Adeniyi, Oladele Vincent},
title = {Colistin utilization at a tertiary hospital in South Africa: an opportunity for antimicrobial stewardship practices},
journal = {Journal of Medical Microbiology},
year = {2024},
doi = {10.1099/jmm.0.001840}
}
EUVIMED